Andrew J Murphy insider trades: Regeneron Pharmaceuticals (REGN) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Andrew reports to the SEC
Open-market buys and sales
15 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 14, 2026 | REGN | ↓ Sell | 4,147 | $772.70 | $3.2M | Direct | Oct 15, 2026 (1d) |
| Aug 14, 2024 | REGN | ↓ Sell | 6,363 | $1153.15 | $7.3M | Direct | Aug 15, 2024 (1d) |
| Mar 14, 2024 | REGN | ↓ Sell | 5,783 | $956.47 | $5.5M | Direct | Mar 15, 2024 (1d) |
| Dec 5, 2023 | REGN | ↓ Sell | 6,536 | $817.44 | $5.3M | Direct | Dec 6, 2023 (1d) |
| Nov 14, 2023 | REGN | ↓ Sell | 6,492 | $799.17 | $5.2M | Direct | Nov 15, 2023 (1d) |
| Nov 15, 2022 | REGN | ↓ Sell | 3,720 | $727.81 | $2.7M | Direct | Nov 16, 2022 (1d) |
| Aug 16, 2022 | REGN | ↓ Sell | 3,513 | $645.49 | $2.3M | Direct | Aug 17, 2022 (1d) |
| May 17, 2022 | REGN | ↓ Sell | 3,543 | $663.68 | $2.4M | Direct | May 18, 2022 (1d) |
| Feb 15, 2022 | REGN | ↓ Sell | 3,540 | $629.34 | $2.2M | Direct | Feb 16, 2022 (1d) |
| Dec 10, 2021 | REGN | ↓ Sell | 7,122 | $666.27 | $4.7M | Direct | Dec 10, 2021 (0d) |
| Nov 16, 2021 | REGN | ↓ Sell | 7,167 | $647.17 | $4.6M | Direct | Nov 17, 2021 (1d) |
| Nov 17, 2020 | REGN | ↓ Sell | 6,628 | $542.73 | $3.6M | Direct | Nov 18, 2020 (1d) |
| Jul 14, 2020 | REGN | ↓ Sell | 11,929 | $626.98 | $7.5M | Direct | Jul 15, 2020 (1d) |
| Jul 14, 2020 | REGN | ↓ Sell | 2,380 | $633.48 | $1.5M | Direct | Jul 15, 2020 (1d) |
| Jan 27, 2020 | REGN | ↓ Sell | 8,000 | $340.91 | $2.7M | Direct | Jan 28, 2020 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other REGN insiders
Open-market trades in the last 12 months
About Andrew J Murphy's insider trades
Andrew J Murphy is Co-Chief Scientific Officer at Regeneron Pharmaceuticals (REGN). Since Jan 27, 2020, Andrew has reported no open-market purchases and 15 sales worth $60.9M on SEC Form 4. In the last 12 months: 1 sale ($3.2M).
Their filings also include shares withheld for taxes (22 filings), option exercises (16 filings), grants and awards (7 filings), gifts (6 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every REGN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.